Drugs Similar to ADENINE 1546

ADDITIVE SOLUTION FORMULA 3 (AS-3) is designed to be added to packed RBC collected in apheresis procedures, and acts to preserve and extend the shelf life of packed RBC products for later transfusion to patients. The solution is intended to be metered by an apheresis device during apheresis procedures or added manually after a collection. Additive Solution Formula 3 (AS-3) is a clear solution that is steam-sterilized and non-pyrogenic. It does not contain bacteriostatic or antimicrobial agents. The formulas of the active ingredients are provided in Table 1. Table 1: Active Ingredients Ingredients Molecular Formula Molecular Weight Dextrose Monohydrate USP C 6 H 12 O 6 ∙ H 2 O 198.17 Trisodium Citrate Dihydrate USP C 6 H 9 Na 3 O 9 294.10 Sodium Chloride USP NaCl 58.44 Monobasic Sodium Phosphate Monohydrate USP NaH 2 PO 4 ∙ H 2 O 137.99 Citric Acid Monohydrate USP C 6 H 8 0 7 ∙ H 2 O 210.14 Adenine USP C 5 H 5 N 5 135.13 Water for Injection USP H 2 O 18.00 Each 100 mL of ADDITIVE SOLUTION FORMULA 3 (AS-3) contains: Dextrose Monohydrate USP 1.10 g; Trisodium Citrate Dihydrate USP 0.59 g; Sodium Chloride USP 0.41 g; Monobasic Sodium Phosphate Monohydrate USP 0.28 g; Citric Acid Monohydrate USP 0.042 g; Adenine USP 0.03 g; and Water for Injection USP. ADDITIVE SOLUTION FORMULA 3 is available in three volumes: 100 mL, 200 mL and 350 mL. The 100 mL bags are individually wrapped with a clear plastic film. Six individually wrapped bags are then vacuum-sealed in a foil pouch, which serves as a vapor barrier to prevent water loss during storage. After you remove the individual solution bags from the foil pouch, you can either leave them in the clear plastic film or remove and discard it. Once the foil pouch has been opened, use all six of the solution bags within 2 weeks. The 200 mL and 350 mL bags are individually wrapped with a clear plastic film. These larger volumes do not require the additional vapor barrier. Once the clear plastic film has been removed, use the solution within 2 weeks. The Polyolefin bag is not made with natural rubber latex. The bag is made from a multilayered film. It contains materials that have been tested to demonstrate the suitability of the container for storing pharmaceutical solutions. The bag is nontoxic and biologically inert. The bag-solution unit is a closed system and is not dependent upon entry of external air during administration.

ADDITIVE SOLUTION FORMULA 3 (AS-3), 300 mL Each 100 mL contains: Citric Acid (Monohydrate), USP 0.042 g Monobasic Sodium Phosphate (Monohydrate), USP 0.276 g Sodium Chloride, USP 0.410 g Adenine, USP 0.030 g Dextrose (Anhydrous), USP 1.000 g Sodium Citrate (Dihydrate), USP 0.588 g containing 15 mEq of Sodium. . Description Description of the product ADDITIVE SOLUTION FORMULA 3 (AS-3), 250 mL Each 100 mL contains: Citric Acid (Monohydrate), USP 0.042 g Monobasic Sodium Phosphate (Monohydrate), USP 0.042 g Sodium Chloride, USP 0.410 g Adenine, USP 0.030 g Dextrose (Anhydrous), USP 1.000 g Sodium Citrate (Dihydrate), USP 0.588 g containing 15 mEq of Sodium. Description

Summary not available yet.

Summary not available yet.

Summary not available yet.

Summary not available yet.

Summary not available yet.

Summary not available yet.

Summary not available yet.

Summary not available yet.

Summary not available yet.

Summary not available yet.

Summary not available yet.

Rejuvesol ® Red Blood Cell Processing Solution ( rejuvesol ® Solution) is a sterile, non-pyrogenic solution of sodium pyruvate, inosine, adenine, dibasic sodium phosphate, and monobasic sodium phosphate in water for injection intended only for use in the extracorporeal rejuvenation of a unit of red blood cell concentrate (RBC). Each 50 mL of rejuvesol ® Solution contains sodium pyruvate 0.550 g, inosine 1.34 g, adenine 0.034 g, dibasic sodium phosphate (heptahydrate) 0.730 g, and monobasic sodium phosphate (monohydrate) 0.311 g, in water for injection, pH 6.7-7.4.

/ PRODUCT SPECIFICATIONS 11.1. This blood bag system includes a 16 gauge × 1 1/2 inch (1.60 × 38 mm) needle with needle cover and either a 450 mL or 500 mL (nominal capacity 600 mL) primary collection bag containing 63 mL or 70 mL, respectively, Citrate Phosphate Dextrose Adenine (CPDA-1) anticoagulant. The Triple blood bag set has one integrally attached empty satellite bag (nominal capacity 400 mL) and one empty XT-612 5 day Platelet bag (nominal capacity 500 mL). The Quadruple blood bag set has two integrally attached empty satellite bags (nominal capacity 400 mL) and one empty XT-612 5 day Platelet bag (nominal capacity 500 mL). 11.2. Blood bag codes ending in A2 are supplied with Integral Diversion Blood Sampling Arm intended to divert and obtain donor samples for laboratory testing prior to collection of the Whole Blood unit. 11.3. Blood bag codes ending in A2 also include a DonorCare Needle Guard pre-attached to the donor tubing. DonorCare Needle Guard device instructions are provided on the reverse side. 11.4. The blood bag collection set is made of PVC (polyvinyl chloride with DEHP plasticizer). 11.5. The blood bag has no components made of natural rubber latex. 11.6. Tubing internal diameter (ID) nominal 3.0 mm. 11.7. Tubing outer diameter (OD) nominal 4.4 mm. 11.8. Donor tubing line maximum 16 segments available.

/ PRODUCT SPECIFICATIONS 11.1. This blood bag system includes a 16 gauge × 1 1/2 inch (1.60 × 38 mm) needle with needle cover and either a 450 mL or 500 mL (nominal capacity 600 mL) primary collection bag containing 63 mL or 70 mL, respectively, Citrate Phosphate Dextrose Adenine (CPDA-1) anticoagulant. The Triple blood bag set has one integrally attached empty satellite bag (nominal capacity 400 mL) and one empty XT-612 5 day Platelet bag (nominal capacity 500 mL). The Quadruple blood bag set has two integrally attached empty satellite bags (nominal capacity 400 mL) and one empty XT-612 5 day Platelet bag (nominal capacity 500 mL). 11.2. Blood bag codes ending in A2 are supplied with Integral Diversion Blood Sampling Arm intended to divert and obtain donor samples for laboratory testing prior to collection of the Whole Blood unit. 11.3. Blood bag codes ending in A2 also include a DonorCare Needle Guard pre-attached to the donor tubing. DonorCare Needle Guard device instructions are provided on the reverse side. 11.4. The blood bag collection set is made of PVC (polyvinyl chloride with DEHP plasticizer). 11.5. The blood bag has no components made of natural rubber latex. 11.6. Tubing internal diameter (ID) nominal 3.0 mm. 11.7. Tubing outer diameter (OD) nominal 4.4 mm. 11.8. Donor tubing line maximum 16 segments available.

/ PRODUCT SPECIFICATIONS 11.1. This blood bag system includes a 16 gauge × 1 1/2 inch (1.60 × 38 mm) needle with needle cover and either a 450 mL or 500 mL (nominal capacity 600 mL) primary collection bag containing 63 mL or 70 mL, respectively, Citrate Phosphate Dextrose Adenine (CPDA-1) anticoagulant. The Triple blood bag set has one integrally attached empty satellite bag (nominal capacity 400 mL) and one empty XT-612 5 day Platelet bag (nominal capacity 500 mL). The Quadruple blood bag set has two integrally attached empty satellite bags (nominal capacity 400 mL) and one empty XT-612 5 day Platelet bag (nominal capacity 500 mL). 11.2. Blood bag codes ending in A2 are supplied with Integral Diversion Blood Sampling Arm intended to divert and obtain donor samples for laboratory testing prior to collection of the Whole Blood unit. 11.3. Blood bag codes ending in A2 also include a DonorCare Needle Guard pre-attached to the donor tubing. DonorCare Needle Guard device instructions are provided on the reverse side. 11.4. The blood bag collection set is made of PVC (polyvinyl chloride with DEHP plasticizer). 11.5. The blood bag has no components made of natural rubber latex. 11.6. Tubing internal diameter (ID) nominal 3.0 mm. 11.7. Tubing outer diameter (OD) nominal 4.4 mm. 11.8. Donor tubing line maximum 16 segments available.

HOMEOPATHIC INDICATIONS: For temporary relief of symptoms related to heartburn and esophageal reflux.** **These statements are based upon traditional homeopathic principles. They have not been reviewed by the Food and Drug Administration.

HOMEOPATHIC INDICATIONS: For temporary relief of mild to moderate arthritic pain and joint stiffness.** **These statements are based upon homeopathic principles. They have not been reviewed by the Food and Drug Administration.

Uses Temporarily relieves symptoms: Backache Stiff, swollen joints Leg cramps Sore tendons and ligaments Hip and knee discomforts Irritability Fatigue Body aches Restless limbs As per various homeopathic materia medicas. Claims based on traditional homeopathic practice, not accepted medical evidence. These uses have not been evaluated by the FDA, and product has not been clinically tested. Reference image:Arthritis Pain and Joint.jpg

Uses Uses for symptomatic relief of ear sounds: Buzzing Roaring Ringing Whistling Sensitivity to noise † as per various homeopathic materia medicas. Claims based on traditional homeopathic practice, not accepted medical evidence. These uses have not been evaluated by the FDA, and product has not been clinically tested. Reference image:Ear Ringing.jpg

INDICATIONS Use according to standard homeopathic indications for self-limiting conditions. Common Materia Medica indications: flu-like symptoms, muscle soreness, bruises.*

HOMEOPATHIC INDICATIONS: For the temporary relief of symptoms related to HHV-6, including fatigue, cognitive and neurological complaints.** **These statements are based upon traditional homeopathic principles. They have not been reviewed by the Food and Drug Administration.

INDICATIONS: May temporarily relieve loss of appetite, stomach upset, nausea, and craving of alcohol.** **Claims based on traditional homeopathic practice, not accepted medical evidence. Not FDA evaluated.

INDICATIONS For the temporary relief of difficulty losing weight or reducing body fat, general weakness, muscle fatigue, dizziness, occasional headache, or irritability.*

Uses For temporary relief of symptoms associated with sciatica: shooting pain, numbness and tingling, burning sensation. Reference image: SciatiPlex.jpg

INDICATIONS Temporarily relieves emotional or mental exhaustion, apathy, or apprehension.*

INDICATIONS For the temporary relief of red, itchy, or inflamed skin, cough, difficulty breathing, runny nose, sneezing, or nasal congestion due to sensitivity to or exposure to household bleach.*

Uses Temporary relief of ocassional numbness, irritability, tingling.

INDICATIONS Temporarily relieves melancholy, apathy, pessimism, or being overly sensitive.*

INDICATIONS For the temporary relief of cough, chills, shortness of breath, muscle aches, occasional headaches, or diarrhea.*

INDICATIONS For the temporary relief of minor muscle or joint pain or inflammation, indigestion, irritability, or confusion.*

INDICATIONS Temporarily relieves apathy, indifference, lost motivation or ambition, or difficulty with comprehension or awareness.*

Uses Temporary relief of increased or decreased thirst, dryness, headaches.

INDICATIONS Temporarily relieves feelings of loneliness, loss, heartache, fear, or insecurity, especially in conjunction with past abuse or trauma.*

Uses Temporary relief of headache, joint pain, skin eruption, itching.

HOMEOPATHIC INDICATIONS: For the temporary relief of symptoms related to consumption of grains, soy, and gluten, including bowel irregularity, occasional diarrhea, occasional constipation, and fatigue.** **These statements are based upon traditional homeopathic principles. They have not been reviewed by the Food and Drug Administration.